Results 1 to 10 of about 22,605 (200)

The Regulation of the Albomycin and Desferrioxamine E Biosynthesis in <i>Streptomyces globisporus</i> bja209. [PDF]

open access: yesMolecules
We identified Streptomyces globisporus bja209 through a targeted screen of actinomycetes from natural habitats using an E. coli JW5503 ΔtolC DualRep2(c) reporter strain.
Buyuklyan JA   +3 more
europepmc   +3 more sources

Desferrioxamine-related ocular toxicity: A case report

open access: yesIndian Journal of Ophthalmology, 2012
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss.
Sumu Simon   +4 more
doaj   +2 more sources

Genome Mining and Molecular Networking-Targeted Discovery of Siderophores with Plant Growth-Promoting Activities from the Marine-Derived <i>Streptomonospora nanhaiensis</i> 12A09<sup>T</sup>. [PDF]

open access: yesMar Drugs
Plant growth regulators (PGRs) significantly contribute to enhancing crop quality and yield. There is an urgent market demand for innovative natural PGRs. Marine natural products have the potential to serve as valuable sources of PGRs.
Bai Y   +6 more
europepmc   +2 more sources

Genetic and biochemical insights into siderophore biosynthesis in the marine fish pathogen Tenacibaculum maritimum. [PDF]

open access: yesSci Rep
Siderophore production is a key fitness trait for bacteria, particularly in iron-limited environments such as marine ecosystems and host tissues. In this study, we identify the tenABECDC2D2hp1-4 gene cluster as responsible for siderophore biosynthesis in
Escribano MP   +7 more
europepmc   +2 more sources

Desferrioxamine-Related Pseudo-Vitelliform Dystrophy and the Effect of Anti-Vascular Endothelial Growth Factor

open access: yesCase Reports in Ophthalmology, 2021
We report a case of a 72-year-old female who developed bilateral pseudo-vitelliform dystrophy after taking desferrioxamine for the treatment of chronic iron overload.
Michael E. Grinton   +2 more
doaj   +1 more source

Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr4+ Complexes

open access: yesMolecules, 2021
Desferrioxamine (DFO) is the current “gold standard” chelator for 89Zr4+, which is used to label monoclonal antibodies for applications in immunopositron emission tomography.
Matteo Savastano   +2 more
doaj   +1 more source

Tenacibactins K–M, cytotoxic siderophores from a coral-associated gliding bacterium of the genus Tenacibaculum

open access: yesBeilstein Journal of Organic Chemistry, 2022
HPLC/DAD-based chemical investigation of a coral-associated gliding bacterium of the genus Tenacibaculum yielded three desferrioxamine-class siderophores, designated tenacibactins K (1), L (2), and M (3).
Yasuhiro Igarashi   +6 more
doaj   +1 more source

Accidental iron poisoning in children – Experience from a teaching institution

open access: yesJournal of Family Medicine and Primary Care, 2023
Background: Acute iron toxicity is fatal in children resulting from an accidental overdose of maternal iron tablets at home. There is scanty literature on children looking at the profile and outcome.
Jolly Chandran   +4 more
doaj   +1 more source

Novel South African Rare Actinomycete Kribbella speibonae Strain SK5: A Prolific Producer of Hydroxamate Siderophores Including New Dehydroxylated Congeners

open access: yesMolecules, 2020
In this paper, we report on the chemistry of the rare South African Actinomycete Kribbella speibonae strain SK5, a prolific producer of hydroxamate siderophores and their congeners. Two new analogues, dehydroxylated desferrioxamines, speibonoxamine 1 and
Kojo Sekyi Acquah   +8 more
doaj   +1 more source

Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent

open access: yesPharmaceuticals, 2023
Mycobacteria cause tuberculosis and other serious diseases. Understanding their mechanisms of resistance to our immune system and exploring novel drugs are critical strategies to combat infections.
Patrícia Vieira de Oliveira   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy